PLAC4 and β-HCG mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21

Prenatal Diagnosis

Volumn 28, Issue 13, 2008, Pages 1262-1267

  Banzola, Irina ^a,c   Rusterholz, Corinne ^a   Zannoni, Letizia ^b   Rizzo, Nicola ^b   Xiao, Yan Zhong ^a   Caramelli, Elisabetta ^c   Holzgreve, Wolfgang ^a   Farina, Antonio ^b,c   Hahn, Sinuhe ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Non invasive prenatal screening; Placental mRNA; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; MESSENGER RNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENE; HUMAN; MATERNAL BLOOD; PLAC4 GENE; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 58049202984     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2163     Document Type: Article

References (35)

1. Bianchi DW, Williams JM, Sullivan LM, et al. 1997. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61: 822-829.
2. Bischof P, Duberg S, Herrmann W, Sizonenko PC. 1982. Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products. Br J Obstet Gynaecol 89: 358-363.
3. Brizot ML, Jauniaux E, Mckie AT, et al. 1995. Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. Hum Reprod 10: 2506-2509.
4. Cuckle HS, Sehmi IK, Jones RG, Mason G. 1999. Low maternal serum PAPP-A and fetal viability. Prenat Diagn 19: 788-790.
5. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191: 1446-1451.
6. Eldar-Geva T, Hochberg A, de Groot N, Weinstein D. 1995. High maternal serum chorionic gonadotropin level in Downs' syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts. J Clin Endocrinol Metab 80: 3528-3531.
7. Farina A, Leshane ES, Lambert-Messerlian GM, et al. 2003. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 49: 239-242.
8. Farina A, Sekizawa A, Purwosunu Y, et al. 2006. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 26: 1115-1120.
9. Frendo JL, Vidaud M, Guibourdenche J, et al. 2000. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab 85: 3700-3707.
10. Go AT, Visser A, Mulders MA, et al. 2007. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma. Prenat Diagn 27: 146-149.
11. Gupta AK, Rusterholz C, Huppertz B, et al. 2005. A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta 26: 59-66.
12. Hahn S, Huppertz B, Holzgreve W. 2005. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 26: 515-526.
13. Kagan KO, Wright D, Baker A, et al. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
14. Lin TM, Halbert SP, Spellacy WN. 1974. Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest 54: 576-582.
15. Lo YM, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
16. Lo YM, Lau TK, Zhang J, et al. 1999. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45: 1747-1751.
17. Lo YM, Tsui NB, Chiu RW, et al. 2007. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13: 218-223.
18. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
19. Massin N, Frendo JL, Guibourdenche J, et al. 2001. Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. Placenta 22(Suppl. A): S93-S97.
20. Muller F, Cuckle H, Teisner B, Grudzinskas JG. 1993. Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy. Prenat Diagn 13: 633-636.
21. Ng EK, El Sheikhah A, Chiu RW, et al. 2004. Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. Clin Chem 50: 1055-1057.
22. Ng EK, Tsui NB, Lau TK, et al. 2003. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 100: 4748-4753.
23. Okazaki S, Sekizawa A, Purwosunu Y, et al. 2006. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. J Med Genet 43(9): e47.
24. Oudejans CB, Tjoa ML, Westerman BA, et al. 2003. Circulating trophoblast in maternal blood. Prenat Diagn 23: 111-116.
25. Poon LL, Leung TN, Lau TK, Lo YM. 2000. Presence of fetal RNA in maternal plasma. Clin Chem 46: 1832-1834.
26. Spencer K. 2007. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 145C: 18-32.
27. Taniguchi R, Koizumi T, Das H, et al. 2000. Trophoblastic cells expressing human chorionic gonadotropin genes in peripheral blood of patients with trophoblastic disease. Life Sci 66: 1593-1601.
28. Troeger C, Zhong XY, Burgemeister R, et al. 1999. Approximately half of the erythroblasts in maternal blood are of fetal origin. Mol Hum Reprod 5: 1162-1165.
29. Tsui NB, Chim SS, Chiu RW, et al. 2004. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 41: 461-467.
30. Wald NJ, Hackshaw AK. 1997. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 17: 821-829.
31. Wald NJ, Rodeck C, Hackshaw AK, et al. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
32. Wong BC, Chiu RW, Tsui NB, et al. 2005. Circulating placental RNA in maternal plasma is associated with a preponderance of 5′ mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring. Clin Chem 51: 1786-1795.
33. Wright A, Zhou Y, Weier JF, et al. 2004. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am J Med Genet A 130A: 354-364.
34. Zhong XY, Burk MR, Troeger C, et al. 2000. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20: 795-798.
35. Zhong XY, Gebhardt S, Hillermann R, et al. 2005. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 51: 1730-1733.